Facebook Linkedin RSS Twitter Youtube
Home 2022

Cardiotoxicity

DNA-Based Nanotransporters Deliver Precise Concentrations of Drug
Drug Discovery

DNA-Based Nanotransporters Deliver Precise Concentrations of Drug

Engineered Heart-on-a-Chip Replicates Drug Responses Found in Adult Humans
News

Engineered Heart-on-a-Chip Replicates Drug Responses Found in Adult Humans

Accurate Prediction of On- and Off-Target Cardiotoxicity with Human iPSC-Derived Cardiomyocytes
On Demand

Accurate Prediction of On- and Off-Target Cardiotoxicity with Human iPSC-Derived Cardiomyocytes

MTTI, Taiwan’s NHRI Launch Cancer Drug Collaboration
Cancer

MTTI, Taiwan’s NHRI Launch Cancer Drug Collaboration

Firms Offer iPSC Cardiac Toxicity Screening
Drug Discovery

Firms Offer iPSC Cardiac Toxicity Screening

Measurement of Cardiomyocyte Contractions
Insights

Measurement of Cardiomyocyte Contractions

ATCC Negotiates Nonexclusive Worldwide Rights to iPS Academia Japan’s Stem Cell IP
News

ATCC Negotiates Nonexclusive Worldwide Rights to iPS Academia Japan’s Stem Cell IP

CDI to Supply iPSC-Derived Human Heart Cells for Roche’s Drug Development Efforts
Drug Discovery

CDI to Supply iPSC-Derived Human Heart Cells for Roche’s Drug Development Efforts

Cardiac Toxicity Leads SuperGen to Discontinue Development of Phase I PIM Inhibitor
Cancer

Cardiac Toxicity Leads SuperGen to Discontinue Development of Phase I PIM Inhibitor

FDA Requires More Clinical Work to Give Cell Therapeutics’ NHL Drug the Go-Ahead
Cancer

FDA Requires More Clinical Work to Give Cell Therapeutics’ NHL Drug the Go-Ahead

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.